Objective: To examine the relationship between body mass index (BMI) and metabolic syndrome for Asian Americans and non-Hispanic Whites (NHWs), given that existing evidence shows racial/ethnic heterogeneity exists in how BMI predicts metabolic syndrome. Research Design and Methods: Electronic health records of 43 507 primary care patients aged 35 years and older with self-identified race/ethnicity of interest (Asian Indian, Chinese, Filipino, Japanese, Korean, Vietnamese or NHW) were analyzed in a mixed-payer, outpatient-focused health-care organization in the San Francisco Bay Area. Results: Metabolic syndrome prevalence is significantly higher in Asians compared with NHWs for every BMI category. For women at the mean age of 55 and BMI of 25 kg m -2 , the predicted prevalence of metabolic syndrome is 12% for NHW women compared with 30% for Asians; similarly for men, the predicted prevalence of metabolic syndrome is 22% for NHWs compared with 43% of Asians. Compared with NHW women and men with a BMI of 25 kg m -2 , comparable prevalence of metabolic syndrome was observed at BMI of 19.6 kg m -2 for Asian women and 19.9 kg m -2 for Asian men. A similar pattern was observed in disaggregated Asian subgroups. Conclusions: In spite of the lower BMI values and lower prevalence of overweight/obesity than NHWs, Asian Americans have higher rates of metabolic syndrome over the range of BMI. Our results indicate that BMI ranges for defining overweight/obesity in Asian populations should be lower than for NHWs.
Introduction
Metabolic syndrome is a constellation of multiple metabolic risk factors that greatly increases risk for cardiovascular mortality 1 and type 2 diabetes. 2 Metabolic syndrome is currently defined by the National Cholesterol Education Program Expert Panel in Adult Treatment Panel III as the presence of three or more of the following factors: elevated fasting glucose (X100 mg per 100 ml), elevated blood pressure (X130/85 mm Hg), reduced high-density lipoprotein (men o40 mg per 100 ml, women o50 mg per 100 ml), and elevated triglycerides (X150 mg per 100 ml), and an elevated waist circumference (X40 inches for men, X35 inches for women). 3 Prospective population studies of people with metabolic syndrome have shown a twofold increase in relative risk for cardiovascular disease events 4 and a fivefold increase for developing diabetes compared with people without the syndrome. 2 Therefore, the components of metabolic syndrome are important treatment targets for reducing cardiovascular disease and diabetes. The National Cholesterol Education Program Expert Panel in Adult Treatment Panel III identifies overweight, obesity and physical inactivity, along with genetic factors that enhance insulin resistance, as the root causes of the metabolic syndrome. 3 The San Antonio Heart Study and the Insulin Resistance Atherosclerosis Study, both population-based longitudinal studies, showed both body mass index (BMI) and waist circumference to be highly predictive of the onset of metabolic syndrome. 5, 6 Subjects with a baseline BMI 430 kg m -2 were between three and eight times more likely to develop metabolic syndrome than those with a BMI o25 kg m -2
. 5 Thus, targeting obesity and obesity-related factors seems to be the most potent strategy to prevent or manage metabolic syndrome. ) or obese (BMI X30.0 kg m -2 ), as shown in previous national studies. [23] [24] [25] To avoid circularity when 
-ORAt least one blood pressure X130/85 mm Hg; OR ICD-9 277.7 Use of blood pressure medications Low HDL cholesterol At least one HDL o50 mg per 100 ml (women) OR o40 mg per 100 ml (men) Hypertriglyceridemia At least one triglyceride X150 mg per 100 ml Metabolic syndrome despite lower BMI in Asians LP Palaniappan et al describing the association between BMI and metabolic syndrome, we excluded the BMI criterion from the five criteria and instead defined metabolic syndrome as any two of the remaining four criteria. The electronic health record data elements for the definition are shown in Table 1 . Metabolic syndrome was additionally defined as having an ICD-9 code 277.7 (physician-diagnosed metabolic syndrome, which was present in only 2% of total participants with metabolic syndrome). Although our redefinition of metabolic syndrome reduces the comparability of our prevalence rates to other studies, our focus is on the internal comparison between Asian Americans and NHWs, for whom it is similarly defined.
Statistical analysis
Univariate. Patient demographics and characteristics were described using means and proportions. Means were compared using analysis of variance and Tukey's comparisons. Proportions of individual metabolic syndrome components were calculated with binomial confidence intervals. ) ( Figure 1) . Next, we analyzed the relationship of metabolic syndrome with BMI, by racial/ethnic group. Models included age, age 2 , BMI, racial/ethnic group and BMI*racial/ethnic group. The interaction terms between BMI and each racial/ethnic group are included in the models so that we can examine whether the effect of BMI on the outcomes differs by race/ethnicity. For example, the additional effect if any of being Asian with high BMI values beyond being Asian or having high BMI values separately. The predicted prevalence was estimated at fixed values of age and plotted against BMI. Statistical significance was determined using the standardized difference in predicted prevalences between racial/ethnic groups on the logit scale. To analyze the relationship of metabolic syndrome and BMI at different ages, results were presented at the representative ages of 35 years, the mean age and 65 years. We repeated this investigation on metabolic syndrome components.
Prevalence rates are presented with 95% confidence intervals or bands. Since 320 models were examined during this study, a Bonferroni type correction was applied and statistical significance was determined at Po0.00016. All statistical analyses were performed using SAS 9.2 (Cary, NC, USA).
Results
Electronic health record data from 43 507 unique patients were included in the analyses ( Table 2 ). The number of unique patients in each racial/ethnic group ranged from 413 in the Korean group to 32 406 in the NHW group. The proportion of women ranged from 46% in Asian Indians to 68% in Japanese. Asian patients as a group were younger than NHWs and had lower BMIs than NHWs. The exception was ) was lower for all Asian groups than for NHWs. Type 2 diabetes or impaired fasting glucose, low high-density lipoprotein and hypertriglyceridemia were all more common among Asians than NHWs.
Age-adjusted metabolic syndrome prevalence rates are presented for four BMI categories (Figure 1 ). Metabolic syndrome is higher in Asians overall than NHWs within every BMI category. The differences are particularly noteworthy in the overweight category in which the rates are 25% for NHWs and 48% for Asians (Po0.00016). Among the Asian subgroups, Asian Indians and Filipinos have uniformly higher prevalence of metabolic syndrome for every BMI category. Figure 2 shows predicted prevalence of metabolic syndrome in NHWs and all Asians over the continuum of BMI. Results were presented for the representative ages of 35 years, the mean age of 55 and 65 years. Compared with NHWs, the predicted prevalence of metabolic syndrome was higher for all Asians at every BMI level over a range of ages. These differences were more pronounced at BMI values [25] [26] [27] [28] [29] [30] Figure 3 shows the predicted prevalence of individual metabolic syndrome components for NHWs and all Asians, over the continuum of BMI and at the mean age. For diabetes or impaired fasting glucose, Asians had uniformly higher predicted prevalence than NHWs across all BMI values in women and men. For high blood pressure, Asians had higher predicted prevalence than NHWs for BMI values 425 kg m -2 in women and men. For both low high-density lipoprotein and hypertriglyceridemia, Asian women had uniformly higher predicted prevalence for BMI o36 kg m -2 and Asian men had higher predicted prevalence than NHWs for BMIs o31 kg m -2 .
Discussion
Obesity, as measured by BMI, is a well-known risk factor for metabolic syndrome. There are many studies that question the validity of BMI as a marker of obesity in Asian populations, given data suggesting higher adiposity at similar levels of BMI. 17, 26, 27 Although more precise measures of adiposity such as waist circumference, computed tomography scans and dual energy X-ray absorptiometry scans may be preferable to BMI to define obesity, BMI is without question the most cost-effective approach. Waist circumference commonly uses four body sites Metabolic syndrome despite lower BMI in Asians LP Palaniappan et al (17) 97 (16) 97 (18) 96 (14) 102 (22) a,b
97 (12) 98 (15) 94 (13) Glucose ( Metabolic syndrome despite lower BMI in Asians LP Palaniappan et al for measurement, and no consensus exists on the optimum site for measurement, especially because it may differ by sex. [28] [29] [30] Another study in which both waist circumference and BMI are available for all participants shows that BMI and waist circumference are highly correlated in specific racial/ethnic populations (NHWs, African Americans and Hispanics), although Asians or Asian subgroups were not examined. 31 Computed tomography scans and dual energy X-ray absorptiometry scans have been used in research settings, but are too expensive to be routinely used in clinical or public health settings. BMI has proved to be a reliable measure of adiposity, or total body fat, irrespective of height. 26, [32] [33] [34] Moreover, the 40 suggest population-specific cut points for obesity, recognizing increased metabolic risk for some populations (Japanese and South Asians) in spite of the similar levels of obesity. Our findings in Asian populations in the United States corroborate this increased disease risk for metabolic syndrome at lower BMI. Although there is limited sample size to make robust comparisons among the Asian-American subgroups, our data strongly suggest heterogeneity among Asian-American subgroups. For example, Japanese patients in our population have higher high-density lipoprotein than the other Asian subgroups. Confirming the contrasts among Asian populations that we observe in other study groups would advance our understanding of this apparent heterogeneity. A strength of our study is that the subgroups examined have similar health-care access, socioeconomic status and geographic location. The distribution of Asian subgroups in the PAMF population is approximately equal to the proportions observed in the United States. 41 Previous work in the PAMF population has shown sufficient validity of the electronic health records 42 to provide accurate disease estimates. Limitations of this study include it being conducted in a single geographic area with somewhat limited sample size in the smaller Asian subgroups (that is, Korean and Vietnamese populations). The PAMF population is insured (30% Preferred Provider Organization, 60% Health Maintenance Organization and 10% Medicare), and thus under-represents the medically underserved. However, these limitations that affect the generalizability of the sample also minimize unmeasured confounding and therefore improve the internal validity of our comparisons; any racial/ethnic differences observed in the PAMF clinical population will likely only be magnified in the general population. We found that Asian Americans generally have lower mean BMI values and lower prevalence of overweight and obesity than NHWs when using traditional BMI ranges in our population of insured northern Californians. However, in spite of the lower BMI, Asian Americans have higher rates of metabolic syndrome for each BMI category (normal, overweight, class I obesity and class II obesity). Over the BMI continuum, Asians are more likely to manifest metabolic syndrome than NHWs. This is true for most of the components of the metabolic syndrome as well. These findings support the World Health Organization recommendation for lower BMI ranges for defining overweight and obesity in Asian populations, including Asian Americans, than for NHWs. Using lower BMI ranges for Asian Americans would allow for earlier and more appropriate screening for the components of metabolic syndrome and may improve preventive efforts.
Asian Americans have higher prevalence of metabolic syndrome than NHWs at each level of BMI. Accurate and early diagnosis of overweight and obesity in Asian Americans is critical to stem the rising tide of metabolic syndrome and type 2 diabetes in this rapidly growing population within the United States. Our work adds to the growing body of evidence that population-specific BMI ranges are necessary for accurate, timely diagnosis of overweight and obesity to prevent metabolic diseases.
